FDA approves 1st drug to delay onset of Type 1 diabetes
By Eric M. Strauss and Morgan Winsor
November 18, 2022
Story
from Health
Eric M. Strauss, Morgan Winsor
, ABC News
Pfizer 3-dose COVID vaccine 80% effective against symptomatic omicron infection for youngest children
By Sony Salzman, Cheyenne Haslett and Eric M. Strauss
May 23, 2022
Story
from Health
Sony Salzman, Cheyenne Haslett, Eric M. Strauss
, ABC News
Pfizer, BioNTech say bivalent COVID-19 booster shot performs better against BA.5 omicron subvariant
By Sony Salzman, Eric M. Strauss and Morgan Winsor
November 4, 2022
Story
from Health
Sony Salzman, Eric M. Strauss, Morgan Winsor
, ABC News
Officials expected to offer 2nd booster shot for those over 50 years old
By Cheyenne Haslett and Eric M. Strauss
March 27, 2022
Story
from Politics
Cheyenne Haslett, Eric M. Strauss
, ABC News
Officials say everyone over 50 can get a 4th COVID shot, but 'especially important' for higher risk people
By Cheyenne Haslett and Eric M. Strauss
March 29, 2022
Story
from Health
Cheyenne Haslett, Eric M. Strauss
, ABC News
FDA expected to recommend boosters for immunocompromised Americans within weeks: Source
By Cheyenne Haslett, Eric M. Strauss and Sasha Pezenik
August 5, 2021
Story
from Health
Cheyenne Haslett, Eric M. Strauss, Sasha Pezenik
, ABC News
Moderna sends vaccine modified for South African variant to NIH for testing
By Eric M. Strauss, Mark Osborne and Arielle Mitropoulos
February 24, 2021
Story
from Health
Eric M. Strauss, Mark Osborne, Arielle Mitropoulos
, ABC News
FDA poised to authorize 3rd vaccine dose for immune-compromised people: Sources
By Eric M. Strauss and Cheyenne Haslett
August 11, 2021
Story
from US
Eric M. Strauss, Cheyenne Haslett
, ABC News